Skip to main content
. 2009 Mar 16;27(14):2405–2414. doi: 10.1200/JCO.2008.21.1516

Table 1.

Host and Treatment Factors Increasing Risk of Selected Medical Complications ≥ 5 Years After Diagnosis of Childhood Cancer

Medical Late Effect Host Factor Treatment Factor
Hypothyroidism8 Female; older age at diagnosis (> 15 years) Radiation to thyroid, any dose, increasing risk with increasing dose
Hyperthyroidism8 Time since diagnosis < 3 years Radiation to thyroid ≥ 35 Gy
Thyroid nodules8 Female; time since diagnosis > 10 years Radiation to thyroid ≥ 25 Gy
Short stature (analysis limited to ALL survivors)13 Female; diagnosis before puberty Cranial radiation > 20 Gy; radiation to spine
Short stature (analysis limited to brain tumor survivors)12 Younger age at diagnosis (< 4 years) Radiation to hypothalamic pituitary axis, any dose, increasing risk with increasing dose
Overweight/obese15 Female; younger age at diagnosis Cranial radiation
Acute ovarian failure6 Diagnosis ≥ 12 years Ovarian radiation > 10 Gy; procarbazine and cyclophosphamide
Premature menopause7 Older attained age Ovarian radiation; alkylating agents
Pulmonary fibrosis25 Chest radiation; cyclophosphamide, bleomycin, busulfan, CCNU, and BCNU
Stroke31,32 Smoking (Hodgkin's disease) Mantle radiation > 40 Gy for Hodgkin's disease; cranial radiation > 30 Gy for brain tumor and leukemia
Motor problems34 Radiation > 50 Gy to frontal regions
Hearing loss34 Radiation > 50 Gy to posterior fossa
Seizure disorder 34 Radiation dose > 30 Gy to any cortical segment of brain

Abbreviations: ALL, acute lymphoblastic leukemia; CCNU, lomustine; BCNU, carmustine.